Safety Pharmacology - Risk Assessment QT Interval Prolongation and Beyond

Current regulatory guidelines for cardiac safety utilize hERG block and QT interval prolongation as risk markers. This strategy has been successful at preventing harmful drugs from being marketed, but criticized for leading to early withdrawal of potentially safe drugs. Here we collected a series of...

Description complète

Détails bibliographiques

Auteurs principaux:	Stefano Morotti, Eleonora Grandi, Esther Pueyo, Blanca Rodriguez
Format:	Online
Langue:	anglais
Publié:	Frontiers Media SA 2021
Sujets:	QP1-981 Q1-390 cardiotoxicity cardiac electrophysiology. drug-induced arrhythmia QT interval prolongation multi-scale modeling thema EDItEUR::M Medicine and Nursing::MF Pre-clinical medicine: basic sciences::MFG Physiology
Accès en ligne:	31949
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!